UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Decentralization, Local Governance, and Localizing the Sustainable Development Goals in Asia and the Pacific

1, 2023

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma

Oncogene, 2013-09, Vol.32 (36), p.4231-4242

2013

Volltextzugriff (PDF)

Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1599-1601

2017

Volltextzugriff (PDF)

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL osteoprotegerin ratio

Leukemia, 2005-11, Vol.19 (11), p.1969-1976

2005

Volltextzugriff (PDF)

Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential

Stem cells international, 2011-01, Vol.2011 (2011), p.1-10

2011

Volltextzugriff (PDF)

Immunophenotype of neoplastic plasma cells in AL amyloidosis

Journal of clinical pathology, 2009-08, Vol.62 (8), p.724-730

2009

Volltextzugriff (PDF)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

Blood cancer journal (New York), 2016-11, Vol.6 (11), p.e500-e500

2016

Volltextzugriff (PDF)

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074

Leukemia, 2004-05, Vol.18 (5), p.962-966

2004

Volltextzugriff (PDF)

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (8), p.731-737

2006

Volltextzugriff (PDF)

Disorder dependence of monopole dynamics in Dy2Ti2O7 probed via thermal transport measurements

Physical review. B, 2018-10, Vol.98 (13), p.134446

2018

Volltextzugriff (PDF)

Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients

Journal of clinical pathology, 2008-02, Vol.61 (2), p.213-216

2008

Volltextzugriff (PDF)

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

Leukemia, 2005-04, Vol.19 (4), p.507-512

2005

Volltextzugriff (PDF)

Quantifying the cost of single-use minims and multidose bottles for eye drops in routine ophthalmic practice: a multicentre study

Canadian journal of ophthalmology, 2022-10, Vol.57 (5), p.312-318

2022

Volltextzugriff (PDF)

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1324-1328

2013

Volltextzugriff (PDF)

The role of markers of bone remodeling in multiple myeloma

Blood reviews, 2005-05, Vol.19 (3), p.125-142

2005

Volltextzugriff (PDF)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.18-23

2012

Volltextzugriff (PDF)

Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia

British journal of haematology, 2003-07, Vol.122 (1), p.160-161

2003

Volltextzugriff (PDF)

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma

European journal of haematology, 2005-11, Vol.75 (5), p.376-383

2005

Volltextzugriff (PDF)

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.364-367

2011

Volltextzugriff (PDF)

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration

Journal of cancer research and clinical oncology, 2004-10, Vol.130 (10), p.623-625

2004

Volltextzugriff (PDF)

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

Leukemia, 2007-05, Vol.21 (5), p.943-948

2007

Volltextzugriff (PDF)

The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome

Journal of clinical pathology, 2009-11, Vol.62 (11), p.1009-1015

2009

Volltextzugriff (PDF)

Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL osteoprotegerin ratio in patients with multiple myeloma

Leukemia, 2004-08, Vol.18 (8), p.1420-1426

2004

Volltextzugriff (PDF)

The Brockhouse X-ray diffraction and scattering beamlines at the Canadian Light Source

Acta crystallographica. Section A, Foundations and advances, 2023-08, Vol.79 (a2), p.C1211-C1211

2023

Volltextzugriff (PDF)

Normal development and function of CD8 + cells but markedly decreased helper cell activity in mice lacking CD4

Nature (London), 1991-09, Vol.353 (6340), p.180-184

1991

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(344)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Decentralization, Local Governance, and Localizing the Sustainable Development Goals in Asia and the Pacific

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma

Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL osteoprotegerin ratio

Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential

Immunophenotype of neoplastic plasma cells in AL amyloidosis

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074

Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients

Disorder dependence of monopole dynamics in Dy2Ti2O7 probed via thermal transport measurements

Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

Quantifying the cost of single-use minims and multidose bottles for eye drops in routine ophthalmic practice: a multicentre study

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT

The role of markers of bone remodeling in multiple myeloma

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome

Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL osteoprotegerin ratio in patients with multiple myeloma

The Brockhouse X-ray diffraction and scattering beamlines at the Canadian Light Source

Normal development and function of CD8 + cells but markedly decreased helper cell activity in mice lacking CD4

Suchergebnisse filtern